137 related articles for article (PubMed ID: 38292196)
1. Network analyses: Inhibition of androgen receptor signaling reduces inflammation in the lung through AR-MAF-IL6 signaling axes.
Wang AR; Baschnagel AM; Ni Z; Brennan SR; Newton HK; Buehler D; Kendziorski C; Kimple RJ; Iyer G
Genes Dis; 2024 May; 11(3):101072. PubMed ID: 38292196
[No Abstract] [Full Text] [Related]
2. The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models.
Handle F; Puhr M; Schaefer G; Lorito N; Hoefer J; Gruber M; Guggenberger F; Santer FR; Marques RB; van Weerden WM; Claessens F; Erb HHH; Culig Z
Mol Cancer Ther; 2018 Dec; 17(12):2722-2731. PubMed ID: 30254184
[TBL] [Abstract][Full Text] [Related]
3. Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain.
Hua Y; Azeem W; Shen Y; Zhang S; Olsen JR; Øyan AM; Ke X; Zhang W; Kalland KH
Pharmacol Res Perspect; 2018 Dec; 6(6):e00437. PubMed ID: 30410767
[TBL] [Abstract][Full Text] [Related]
4. Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells.
Izumi K; Mizokami A
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30871130
[TBL] [Abstract][Full Text] [Related]
5. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis.
Dong H; Xu J; Li W; Gan J; Lin W; Ke J; Jiang J; Du L; Chen Y; Zhong X; Zhang D; Yeung SJ; Li X; Zhang H
J Pathol; 2017 Mar; 241(4):448-462. PubMed ID: 27801498
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer.
Hammacher A; Thompson EW; Williams ED
Int J Biochem Cell Biol; 2005 Feb; 37(2):442-50. PubMed ID: 15474988
[TBL] [Abstract][Full Text] [Related]
8. Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma.
Yanase T; Fan W
Vitam Horm; 2009; 80():649-66. PubMed ID: 19251054
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
Fan W; Yanase T; Morinaga H; Okabe T; Nomura M; Daitoku H; Fukamizu A; Kato S; Takayanagi R; Nawata H
J Biol Chem; 2007 Mar; 282(10):7329-38. PubMed ID: 17202144
[TBL] [Abstract][Full Text] [Related]
10. The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.
Lim SC; Geleta B; Maleki S; Richardson DR; Kovačević Ž
J Biol Chem; 2021 Dec; 297(6):101414. PubMed ID: 34785213
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
12. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
13. Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer.
Jinna N; Rida P; Smart M; LaBarge M; Jovanovic-Talisman T; Natarajan R; Seewaldt V
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012111
[TBL] [Abstract][Full Text] [Related]
14. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression.
Tsukamoto H; Fujieda K; Hirayama M; Ikeda T; Yuno A; Matsumura K; Fukuma D; Araki K; Mizuta H; Nakayama H; Senju S; Nishimura Y
Cancer Res; 2017 May; 77(9):2279-2291. PubMed ID: 28235765
[TBL] [Abstract][Full Text] [Related]
15. Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
Jin BR; Kim HJ; Na JH; Lee WK; An HJ
J Adv Res; 2024 Mar; 57():135-147. PubMed ID: 37061215
[TBL] [Abstract][Full Text] [Related]
16. Notch signaling regulates nuclear androgen receptor AR and membrane androgen receptor ZIP9 in mouse Sertoli cells.
Kamińska A; Pardyak L; Marek S; Wróbel K; Kotula-Balak M; Bilińska B; Hejmej A
Andrology; 2020 Mar; 8(2):457-472. PubMed ID: 31468707
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
18. Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancer.
Li X; Li F; Ye F; Guo H; Chen W; Jin J; Wang Y; Dai P; Shi H; Tao H; Dang W; Ding Y; Wang M; Jiang H; Chen K; Zhang N; Gao D; Zhang Y; Luo C
Cell Rep; 2023 Jul; 42(7):112798. PubMed ID: 37453063
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
Fernandez EV; Reece KM; Ley AM; Troutman SM; Sissung TM; Price DK; Chau CH; Figg WD
Mol Pharmacol; 2015 Jun; 87(6):1006-12. PubMed ID: 25829060
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells.
Kaikkonen S; Paakinaho V; Sutinen P; Levonen AL; Palvimo JJ
Mol Endocrinol; 2013 Feb; 27(2):212-23. PubMed ID: 23192983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
